Description:

NSABP PROTOCOL B-35 Treatment Form for Tamoxifen/Anastrozole NCT00053898 Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A051E957-2260-0392-E034-080020C9C0E0

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A051E957-2260-0392-E034-080020C9C0E0

  1. 8/26/12 8/26/12 -
  2. 5/22/15 5/22/15 -
  3. 6/3/15 6/3/15 -
Uploaded on:

June 3, 2015

DOI:
To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

NSABP PROTOCOL B-35 Treatment Form for Tamoxifen/Anastrozole NCT00053898

Form T (04-30-2002) Submit this form when Tamoxifen/Anastrozole therapy has ended or if the patient did not begin Tamoxifen/Anastrozole.

Header Module
Are data amended? (If Yes, circle the amended items in red.)
Summary Of Tamoxifen/anastrozole Administration
Reason for end of treatment
Reason Treatment Ended (Select the reason that best explains why treatment has ended, or why the patient did not begin treatment.)

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial